$4.65
0.204.49%
Last update: Nov 6, 5:11 PM
Prime Medicine Inc
PRMENASDAQ
The average analyst price target for Prime Medicine is $9.60, 106.5% above the current price. Of 13 analysts, 11 rate it Buy and 2 Hold. Targets range from $4.25 to $18. The latest change came on Aug 19, 2026, when BMO Capital initiated coverage of Prime Medicine with an Outperform rating and a $9 price target.
Price Target Range — 12 Quarters
Analyst Consensus — 13 Analysts
Rating Trend — Last 9 Months
